Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Hope S. Rugo

TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer

Journal of Clinical Oncology

English

Pathologic Complete Response Predicts Recurrence-Free Survival More Effectively by Cancer Subset: Results From the I-Spy 1 TRIAL—CALGB 150007/150012, ACRIN 6657

Journal of Clinical Oncology

English

MONARCH 1, a Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients With Refractory HR + /HER2 − Metastatic Breast Cancer

Clinical Cancer Research

Cancer Research

Oncology

2017

English

Quantitative Whole Genome Sequencing of Circulating Tumor Cells Enables Personalized Combination Therapy of Metastatic Cancer

Cancer Research

Oncology

2017

English

Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology

Journal of the National Comprehensive Cancer Network : JNCCN

Medicine

Oncology

2020

English

Palbociclib With Letrozole in Postmenopausal Women With ER+/HER2− Advanced Breast Cancer: Hematologic Safety Analysis of the Randomized PALOMA‐2 Trial

English

TBCRC 002: A Phase II, Randomized, Open-Label Trial of Preoperative Letrozole With or Without Bevacizumab in Postmenopausal Women With Newly Diagnosed Stage 2/3 Hormone Receptor-Positive and HER2-negative Breast Cancer

Breast Cancer Research

Cancer Research

Oncology

2020

English

Chemotherapy Response and Recurrence-Free Survival in Neoadjuvant Breast Cancer Depends on Biomarker Profiles: Results From the I-Spy 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

Breast Cancer Research and Treatment

Cancer Research

Oncology

2011

English

The Characterization, Management, and Future Considerations for ErbB-family TKI-associated Diarrhea

Breast Cancer Research and Treatment

Cancer Research

Oncology

2019

English

Fixed Combination of Oral NEPA (Netupitant‐palonosetron) for the Prevention of Acute and Delayed Chemotherapy‐induced Nausea and Vomiting in Patients Receiving Multiple Cycles of Chemotherapy: Efficacy Data From 2 Randomized, Double‐blind Phase III Studies

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Hope S. Rugo

TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer

Pathologic Complete Response Predicts Recurrence-Free Survival More Effectively by Cancer Subset: Results From the I-Spy 1 TRIAL—CALGB 150007/150012, ACRIN 6657

MONARCH 1, a Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients With Refractory HR + /HER2 − Metastatic Breast Cancer

Quantitative Whole Genome Sequencing of Circulating Tumor Cells Enables Personalized Combination Therapy of Metastatic Cancer

Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology

Palbociclib With Letrozole in Postmenopausal Women With ER+/HER2− Advanced Breast Cancer: Hematologic Safety Analysis of the Randomized PALOMA‐2 Trial

TBCRC 002: A Phase II, Randomized, Open-Label Trial of Preoperative Letrozole With or Without Bevacizumab in Postmenopausal Women With Newly Diagnosed Stage 2/3 Hormone Receptor-Positive and HER2-negative Breast Cancer

Chemotherapy Response and Recurrence-Free Survival in Neoadjuvant Breast Cancer Depends on Biomarker Profiles: Results From the I-Spy 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

The Characterization, Management, and Future Considerations for ErbB-family TKI-associated Diarrhea

Fixed Combination of Oral NEPA (Netupitant‐palonosetron) for the Prevention of Acute and Delayed Chemotherapy‐induced Nausea and Vomiting in Patients Receiving Multiple Cycles of Chemotherapy: Efficacy Data From 2 Randomized, Double‐blind Phase III Studies